NOVONORM cpr 2 mg 90 pce
7680545710461
CH-54571
A10BX02
07.06.2.
1 / 3
google
Details
- Product number
- 5457103
- CPT
- -
- Packaging group
- 90
- Unit
- Tablette(n)
- Composition
- repaglinidum 2 mg, poloxamerum 188, povidonum K 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas, E 172 (rubrum) pro compresso.
Articles (1)
NovoNorm 2,0 mg, Tabletten
Tabletten
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
repaglinidum
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
poloxamerum 188
|
- | Substance | HNIDK |
|
povidonum K 25
|
- | Substance | HNIDK |
|
megluminum
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
calcii hydrogenophosphas
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
glycerolum (85 per centum)
|
- | Substance | HBESI |
|
polacrilinum kalicum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 54571
- Drug name
- NovoNorm, Tabletten
- Galenic form
- TAB
- ATC Code
- A10BX02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 28/09/1999
- Authorization expiration date
- 31/03/2026
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NOVONORM cpr 2 mg 90 pce
- Description (DE)
- NOVONORM Tabl 2 mg 90 Stk
- Market launch
- 28/09/1999
- Market withdrawal
- 31/03/2026
- Narcotic (BTM)
- No